Drug Recall

 

HPS Pharmacies wish to advise that Seqirus Australia Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA), have given notice of a drug recall of:

Burinex®1mg Tablets
Bumetanide
ARTG 51734

The affected lots are:

Lot Number

Expiry

FC4466

November 2016

FC5521

November 2016

 

This recall has been initiated as a precautionary measure following receipt of an out of specification stability result for the degradation impurity, metanide. A safety assessment has confirmed there is no risk to patient safety.

Please inspect your stocks and quarantine all products from the batch stated above for return to your supplier for a refund.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Seqius on 1800 008 275.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates